Volume 4 Issue 2
Apr.  2013
Turn off MathJax
Article Contents
Chan ZHAO, Mei-fen ZHANG, Fang-tian DONG. Efficacy of Surgical Removal of Subretinal Fibrosis in Patients with Vogt-Koyanagi-Harada Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2013, 4(2): 109-112. doi: 10.3969/j.issn.1674-9081.2013.02.005
Citation: Chan ZHAO, Mei-fen ZHANG, Fang-tian DONG. Efficacy of Surgical Removal of Subretinal Fibrosis in Patients with Vogt-Koyanagi-Harada Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2013, 4(2): 109-112. doi: 10.3969/j.issn.1674-9081.2013.02.005

Efficacy of Surgical Removal of Subretinal Fibrosis in Patients with Vogt-Koyanagi-Harada Disease

doi: 10.3969/j.issn.1674-9081.2013.02.005
More Information
  •   Objective  To evaluate the clinical efficacy of surgical removal of subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease (VKH).  Methods  The clinical data of VKH patients who underwent trans pars plana vitrectomy and subretinal fibrosis removal in our hospital from January 2008 to December 2011 were retrospectively analyzed.  Results  Two male and one female VKH patients (4 eyes), with an average age of 40.7 years (31 to 48 years), were included in this case series. Before surgery, of the 4 eyes, all had subretinal fibrosis in the macula, 1 had mild cataract, and 1 had severe cataract. All the 4 eyes underwent conventional 20-gauge trans pars plana vitrectomy, retinotomy and subretinal fibrosis removal, of which 1 eye was tamponed with C3F8 and the rest 3 were tamponed with silicon oil. An additional lensectomy preserving the anterior capsule with intraocular lens (IOL) implantation was performed in the eye with severe cataract during vitrectomy. No severe perioperative complication was observed. All the 3 silicon oil tamponed eyes underwent successful surgical removal of silicon oil without retinal detachment during follow-up. The 2 eyes without preoperative cataract developed cataract during the follow-up after subretinal fibrosis removal and were successfully treated with phacoemulsification and IOL implantation. Exacerbation of cataract was observed in the eye with mild preoperative cataract and was treated with trans pars plana lensectomy preserving the anterior capsule with IOL implantation during silicon oil removal surgery. The patients were followed up for 1 to 6 months after the last surgical intervention (3.8 months on average) and no active ocular inflammation was observed. When compared to preoperative conditions, improvement in visual acuity was observed in all the 4 eyes in the last follow up visit.  Conclusions  Surgical removal may be a potentially effective treatment for subretinal fibrosis in the macula in VKH patients. Cataract is a common complication after this surgery and requires further surgical intervention.
  • loading
  • [1] Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome[J]. Surv Ophthalmol, 1995, 39:265-292. doi:  10.1016/S0039-6257(05)80105-5
    [2] Rajendram R, Evans M, Rao NA. Vogt-Koyanagi-Harada disease[J]. Int Ophthalmol Clin, 2005, 45:115-134. https://pubmed.ncbi.nlm.nih.gov/27241814/
    [3] Andreoli CM, Foster CS. Vogt-Koyanagi-Harada disease[J]. Int Ophthalmol Clin, 2006, 46:111-122. doi:  10.1097/00004397-200604620-00011
    [4] Yang P, Ren Y, Li B, et al. Clinical characteristics of VogtKoyanagi-Harada syndrome in Chinese patients[J]. Ophthalmology, 2007, 114:606-614. doi:  10.1016/j.ophtha.2006.07.040
    [5] 杨培增, 张震, 王红, 等.葡萄膜炎的临床类型及病因探讨[J].中华眼底病杂志, 2002, 18:253-255. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhydb200204001
    [6] Read RW, Rechodouni A, Butani N, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease[J]. Am J Ophthalmol, 2001, 131:599-606. doi:  10.1016/S0002-9394(01)00937-0
    [7] Lertsumitkul S, Whitcup SM, Nussenblatt RB, et al. Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome[J]. Graefes Arch Clin Exp Ophthalmol, 1999, 237:1039-1045. doi:  10.1007/s004170050342
    [8] Zhao C, Zhang MF, Dong FT, et al. Spectral domain optical coherence tomography of Vogt-Koyanagi-Harada disease:novel findings and new insights into the pathogenesis[J]. Chin Med Sci J, 2012, 27:29-34. doi:  10.1016/S1001-9294(12)60019-4
    [9] Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease:report of an international committee on nomenclature[J]. Am J Ophthalmol, 2001, 131:647-652. doi:  10.1016/S0002-9394(01)00925-4
    [10] Kuo IC, Rechdouni A, Rao NA, et al. Subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease[J]. Ophthalmology, 2000, 107:1721-1728. doi:  10.1016/S0161-6420(00)00244-X
    [11] Bykhovskaya I, Thorne JE, Kempen JH, et al. Vogt-Koyanagi-Harada disease:clinical outcomes[J]. Am J Ophthalmol, 2005, 140:674-678. https://www.ncbi.nlm.nih.gov/pubmed/16226518
    [12] Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada disease[J]. Semin Ophthalmol, 2005, 20:183-190. doi:  10.1080/08820530500232126
    [13] Tugal-Tutkun I, Ozyazgan Y, Akova YA, et al. The spectrum of Vogt-Koyanagi-Harada disease in Turkey:VKH in Turkey[J]. Int Ophthalmol, 2007, 27:117-123. doi:  10.1007/s10792-006-9001-1
    [14] Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition[J]. J Clin Invest, 2009, 119:1420-1428. doi:  10.1172/JCI39104
    [15] Saika S, Yamanaka O, Sumioka T, et al. Fibrotic disorders in the eye:targets of gene therapy[J]. Prog Retin Eye Res, 2008, 27:177-196. doi:  10.1016/j.preteyeres.2007.12.002
    [16] 董方田, 张承芳.黄斑下脉络膜新生血管膜的手术治疗及随访观察[J].中华眼科杂志, 1997, 33:251-254. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyk199704004
    [17] Gass JD. Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes[J]. Am J Ophthalmol, 1994, 118:285-298. doi:  10.1016/S0002-9394(14)72951-4
    [18] Grossniklaus HE, Gass JD. Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes[J]. Am J Ophthalmol, 1998, 126:59-69. doi:  10.1016/S0002-9394(98)00145-7
    [19] Rao NA. Pathology of Vogt-Koyanagi-Harada disease[J]. Int Ophthalmol, 2007, 27:81-85. doi:  10.1007/s10792-006-9029-2
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(1)

    Article Metrics

    Article views (119) PDF downloads(4) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return